Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 0 | 10 | 0 | 33 | 0 |
| Operating Expenses | 19,451 | 18,676 | 11,314 | 19,911 | 6,307 |
| Operating Income | -19,451 | -18,666 | -11,314 | -19,878 | -6,307 |
| Interest Expense | N/A | N/A | N/A | N/A | 35 |
| Other Income | 194 | 365 | 494 | 133,578 | -44,174 |
| Pre-tax Income | -19,257 | -18,301 | -10,820 | 113,700 | -50,516 |
| Income Tax | 59 | 98 | 42 | 42 | 9 |
| Net Income Continuous | -19,316 | -18,399 | -10,862 | 113,658 | -50,525 |
| Net Income | $-19,316 | $-18,399 | $-10,862 | $113,658 | $-50,525 |
| EPS Basic Total Ops | -0.18 | -0.18 | -0.11 | 1.49 | -0.58 |
| EPS Basic Continuous Ops | -0.18 | -0.18 | -0.11 | 1.49 | -0.58 |
| EPS Diluted Total Ops | -0.18 | -0.18 | -0.11 | 1.49 | -0.58 |
| EPS Diluted Continuous Ops | -0.18 | -0.18 | -0.11 | 1.49 | -0.58 |
| EBITDA(a) | $-19,403 | $-18,613 | $-11,273 | $111,366 | $-50,284 |